DEFA14A

Proxy Materials

Chemomab Therapeutics Ltd. Filed 2026-11-10 Acc 0001493152-26-051035

Documents 1

DEFA14A Proxy Materials , formdefa14a.htm

Around this filing

2026-11-10 SCHEDULE 13D Beneficial Ownership Report
2026-11-10 DEFA14A Proxy Materials
2026-11-03 6-K Report of Foreign Issuer
2022-05-31 DEFA14A Proxy Materials

Link to a passage

External

SEC EDGAR (opens in new tab)